The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning. The agency to date has not received any adverse event reports associated with the vulnerabilities, announced in a July advisory from the Department of Homeland Security. The vulnerabilities exist in IPnet, a third-party software component that supports network communications between computers. The software is part of several operating systems and may be used in a wide range of medical and industrial devices.
 

Related News Articles

Headline
The Federal Bureau of Investigation, Cybersecurity and Infrastructure Security Agency, Department of Health and Human Services, and Multi-State Information…
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
The Department of Justice May 7 announced more than two dozen criminal charges against Dimitry Yuryevich Khoroshev, 31, of Voronezh, Russia, for his alleged…
Headline
The AHA and other national hospital groups May 8 sent a letter to UnitedHealth Group, urging the organization to formally accept responsibility for issuing…
Headline
The Cybersecurity and Infrastructure Security Agency May 3 extended the comment period to July 3 for the April 4 proposed rule that would implement cyber…
Headline
The Biden Administration April 30 released a memo announcing updated critical infrastructure protection requirements, which include the Cybersecurity &…